Product Description
Levocetirizine
» Possesses decongestant effect by decreasing the reversibility of nasal airflow
Montelukast
» Reduces number of activated mast cells and eosinophil responsible for contraction of bronchitis
-
Asthma: Seasonal Allergic Rhinitis - In Pediatric Patients 2 Years of Age & Older
-
Perennial Allergic Rhinitis- In Pediatric Patients 6 Months of Age & Older
-
Persistant Allergic Rhinitis- Improve Quality Of Life - Better Than Mometasone Alone
Montelukast plus Levocetirizine is a more effective strategy than monotherapy in the treatment of Persistant Allergic Rhinitis. Combination with Levocetirizine may have a beneficial effect on clinical improvement of middle ear fluid in children with otitis media with effusion (OME).